Senzime to launch Next-Generation TetraGraph System at ANESTHESIOLOGY 2024 Conference
Senzime AB announces the launch of its next-generation TetraGraph system at the ANESTHESIOLOGY 2024 conference in Philadelphia. The new system features TetraGraph Adaptive Intelligence™, a suite of smart algorithms for precision-based monitoring and automated workflows. It also includes a revolutionary user interface with the TetraGraph Level-of-Block Gauge™ and a 6th generation EMG-algorithm with 4x higher resolution for improved clinical accuracy.
The system, developed in collaboration with leading anesthesiologists, is engineered using sustainable materials and manufactured in an ISO14001 certified process. It will be marketed alongside the classic TetraGraph introduced in 2019. Customer deliveries will begin in the US during Q4 2024, in Europe during Q1 2025, and other global regions throughout 2025.
Senzime AB annuncia il lancio del suo sistema TetraGraph di nuova generazione alla conferenza ANESTHESIOLOGY 2024 a Philadelphia. Il nuovo sistema è dotato di TetraGraph Adaptive Intelligence™, un insieme di algoritmi intelligenti per il monitoraggio basato sulla precisione e flussi di lavoro automatizzati. Include anche un'interfaccia utente rivoluzionaria con il TetraGraph Level-of-Block Gauge™ e un algoritmo EMG di 6ª generazione con risoluzione 4 volte superiore per una maggiore precisione clinica.
Il sistema, sviluppato in collaborazione con anestesisti di fama, è progettato utilizzando materiali sostenibili e prodotto in un processo certificato ISO14001. Sarà commercializzato insieme al classico TetraGraph introdotto nel 2019. Le consegne ai clienti inizieranno negli Stati Uniti nel Q4 2024, in Europa nel Q1 2025 e in altre regioni globali durante il 2025.
Senzime AB anuncia el lanzamiento de su sistema TetraGraph de nueva generación en la conferencia ANESTHESIOLOGY 2024 en Filadelfia. El nuevo sistema cuenta con TetraGraph Adaptive Intelligence™, un conjunto de algoritmos inteligentes para el monitoreo basado en precisión y flujos de trabajo automatizados. También incluye una interfaz de usuario revolucionaria con el TetraGraph Level-of-Block Gauge™ y un algoritmo EMG de 6ª generación con 4 veces más resolución para una mayor precisión clínica.
El sistema, desarrollado en colaboración con anestesiólogos de renombre, está diseñado utilizando materiales sostenibles y fabricado en un proceso certificado ISO14001. Se comercializará junto al clásico TetraGraph introducido en 2019. Las entregas a los clientes comenzarán en EE. UU. durante el Q4 de 2024, en Europa durante el Q1 de 2025, y en otras regiones globales a lo largo de 2025.
Senzime AB는 필라델피아에서 열리는 ANESTHESIOLOGY 2024 컨퍼런스에서 차세대 TetraGraph 시스템의 출시를 발표했습니다. 새로운 시스템은 TetraGraph Adaptive Intelligence™를 특징으로 하며, 이는 정밀 모니터링 및 자동화된 작업 흐름을 위한 스마트 알고리즘 모음입니다. 또한 TetraGraph Level-of-Block Gauge™와 임상 정확성을 높이기 위한 4배 더 높은 해상도의 6세대 EMG 알고리즘을 갖춘 혁신적인 사용자 인터페이스도 포함되어 있습니다.
이 시스템은 저명한 마취과 의사들과 협력하여 개발되었으며, 지속 가능한 소재를 사용하고 ISO14001 인증 프로세스에서 제조되었습니다. 2019년에 도입된 클래식 TetraGraph와 함께 판매될 예정입니다. 고객 배송은 2024년 4분기에는 미국에서, 2025년 1분기에는 유럽에서, 2025년 동안 다른 글로벌 지역에서 시작될 예정입니다.
Senzime AB annonce le lancement de son système TetraGraph de nouvelle génération lors de la conférence ANESTHESIOLOGY 2024 à Philadelphie. Le nouveau système est doté de TetraGraph Adaptive Intelligence™, une suite d'algorithmes intelligents pour un suivi basé sur la précision et des flux de travail automatisés. Il comprend également une interface utilisateur révolutionnaire avec le TetraGraph Level-of-Block Gauge™ et un algorithme EMG de 6ème génération avec une résolution 4 fois plus élevée pour une meilleure précision clinique.
Le système, développé en collaboration avec des anesthésistes de renom, est conçu à partir de matériaux durables et fabriqué dans un processus certifié ISO14001. Il sera commercialisé aux côtés du TetraGraph classique introduit en 2019. Les livraisons aux clients commenceront aux États-Unis au quatrième trimestre 2024, en Europe au premier trimestre 2025, et dans d'autres régions du monde tout au long de 2025.
Senzime AB kündigt die Einführung seines NexGeneration TetraGraph-Systems auf der ANESTHESIOLOGY 2024-Konferenz in Philadelphia an. Das neue System verfügt über TetraGraph Adaptive Intelligence™, eine Sammlung intelligenter Algorithmen für prämissionsbasiertes Monitoring und automatisierte Arbeitsabläufe. Es beinhaltet auch eine revolutionäre Benutzeroberfläche mit dem TetraGraph Level-of-Block Gauge™ und einem 6. Generation EMG-Algorithmus mit 4x höherer Auflösung für verbesserte klinische Genauigkeit.
Das System, das in Zusammenarbeit mit führenden Anästhesisten entwickelt wurde, wird aus nachhaltigen Materialien hergestellt und in einem ISO14001-zertifizierten Prozess gefertigt. Es wird zusammen mit dem klassischen TetraGraph vermarktet, das 2019 vorgestellt wurde. Die Auslieferungen an Kunden beginnen in den USA im 4. Quartal 2024, in Europa im 1. Quartal 2025 und in anderen globalen Regionen im Laufe des Jahres 2025.
- Launch of next-generation TetraGraph system with advanced features
- Collaboration with industry leaders in product development
- Use of sustainable materials and environmentally friendly manufacturing process
- Planned expansion of customer deliveries across global markets
- None.
UPPSALA, SE / ACCESSWIRE / October 15, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB, a leader in perioperative patient monitoring solutions, announces the launch of its next-generation TetraGraph system at the annual ANESTHESIOLOGY 2024 conference commencing on October 18th, 2024, in Philadelphia, USA.
The next-generation TetraGraph is designed to redefine the standards of quantitative train-of-four (TOF) monitoring and enhance patient safety. New features include:
Neuromuscular monitoring just got a lot smarter. Introducing TetraGraph Adaptive Intelligence™ including a suite of smart algorithms enabling true precision-based monitoring and automated workflows throughout the perioperative journey.
Revolutionary, new user interface. The TetraGraph Level-of-Block Gauge™ makes complex neuromuscular monitoring understandable to help accelerate alignment to new clinical guidelines.
Advancing Beyond the Twitch. Powered by decades of science and a 6th generation EMG-algorithm with 4x higher resolution for unprecedented clinical accuracy, real-time data trends, and external interoperability.
"I am very excited to unveil our next-generation TetraGraph system, truly an industry game changer and the result of years of extensive research, innovation and collaborations with leading anesthesiologists across the globe. The new TetraGraph represents a paradigm shift in the operating room and opens for accelerated widespread adoption to guidelines by redefining the industry standards for quantitative neuromuscular monitoring", commented Philip Siberg, CEO of Senzime.
The next-generation TetraGraph system has been developed in close partnership with industry leaders, including leading US anesthesiologists. It is first in its space to be engineered using sustainable materials and manufactured in an environmentally friendly ISO14001 certified process. The high-resolution, future-proofed platform has capabilities to integrate additional software features and connects to the industry's most comprehensive portfolio of EMG-based sensors.
The new next-generation TetraGraph will be marketed alongside the classic, first-generation TetraGraph that was introduced to the market in 2019 and now used in thousands of operating rooms across the globe.
For a hands-on demonstration of the next-generation TetraGraph system, visit Senzime's booth #16003 at the ANETHESIOLOGY® 2024 congress in Philadelphia on Oct 18-20, 2024.
An introductory webinar will also be held on October 30, 2024, at 15:00-15:30 CET / 09:00-09:30 am US Eastern Time. Register at https://senzime.webinargeek.com/nextgen .
Customer deliveries of the next-generation TetraGraph will commence in the US during Q4 2024, in Europe during Q1 2025 and other global regions to follow in 2025 and onwards.
For more information, see https://www.senzime.com/nextgen
For press images, see https://www.senzime.com/en/media-toolkit
For further information, please contact:
Philip Siberg, CEO of Senzime AB
Phone: +46 (0) 707 90 67 34, e-mail: philip.siberg@senzime.com
Slavoljub Grujicic, CFO
Phone: +46 (0) 76 306 60 11, e-mail: slavoljub.grujicic@senzime.com
About Senzime
Senzime, headquartered in Sweden, is a leading medical device company that develops, manufactures, and markets CE- and FDA-cleared patient monitoring systems. The company provides an innovative portfolio of solutions, including the TetraGraph® and ExSpiron® 2Xi for accurate monitoring of neuromuscular and respiratory functions, typically under and after surgery. The goal is to help eliminate in-hospital complications, and radically reduce health care costs related to surgical and high acuity procedures.
Senzime targets a market opportunity valued more than SEK 40 billion per year, and operates with sales teams in the world's leading markets. The company's shares are listed on Nasdaq Stockholm Main Market (Nasdaq: SEZI) and cross-traded in the US on the OTCQX market (OTCQX: SNZZF). More information is available at senzime.com .
Image Attachments
Attachments
Senzime to launch Next-Generation TetraGraph System at ANESTHESIOLOGY 2024 conference
SOURCE: Senzime
View the original press release on accesswire.com
FAQ
When will Senzime (SNZZF) launch its next-generation TetraGraph system?
What are the key features of Senzime's (SNZZF) new TetraGraph system?
When will customer deliveries of Senzime's (SNZZF) next-generation TetraGraph begin?
How does Senzime's (SNZZF) new TetraGraph system contribute to sustainability?
